Influence of media and testing methodology on susceptibility to tigecycline of Enterobacteriaceae with reported high tigecycline MIC

Journal of Clinical Microbiology

Volumn 48, Issue 6, 2010, Pages 2243-2246

  Torrico, M ^a   Gonzalez N ^a   Gimenez M J ^a   Alou, L ^a   Sevillano, D ^a   Navarro, D ^b   Diaz Antolin M P ^c   Larrosa, N ^d   Aguilar, L ^a   Garcia Escribano, N ^e  

^a SCHOOL OF MEDICINE   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c HOSPITAL SON LLÀTZER   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TIGECYCLINE;

AGAR DILUTION; AGAR MEDIUM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BROTH DILUTION; CONTROLLED STUDY; DISK DIFFUSION; ENTEROBACTERIACEAE; EPSILOMETER TEST; KLEBSIELLA PNEUMONIAE; METHODOLOGY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SERRATIA MARCESCENS;

ANTI-BACTERIAL AGENTS; CULTURE MEDIA; ENTEROBACTERIACEAE; HUMANS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE;

ENTEROBACTERIACEAE;

EID: 77952914006     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00119-10     Document Type: Article

References (15)

1. Bolmström, A., A. Karlsson, A. Engelhardt, P. Ho, P. J. Petersen, P. A. Bradford, and C. H. Jones. 2007. Validation and reproducibility assessment of tigecycline MIC determinations by Etest. J. Clin. Microbiol. 45:2474-2479.
2. Camarena, J. J., R. Gonzalez, R. Zaragoza, J. C. Navarro, S. Sancho, and J. M. Nogueira. 2007. Actividad in vitro de tigeciclina frente Acinetobacter baumannii: variaciones de CMIs por E-test dependientes del tipo de medio Mueller-Hinton II utilizado en rutina, abstr. 025. Abstr. 12th Reunión de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). Enferm. Infect. Microbiol. Clin. 25(Espec. Congr.):58.
3. Canigia, L. F., and C. Bantar. 2008. Susceptibility testing of tigecycline against Acinetobacter spp. by disc diffusion method: withdrawing a therapeutic option by varying the Mueller-Hinton agar? J. Antimicrob. Chemother. 62:1463-1464.
4. Casal, M., F. Rodríguez, B. Johnson, E. Garduno, F. Tubau, R. O. de Lejarazu, A. Tenorio, M. J. Giménez, R. Bartolomé, C. Garcia-Rey, L. Aguilar, and N. García-Escribano. 2009. Influence of testing methodology on the tigecycline activity profile against presumably tigecycline-non-susceptible Acinetobacter spp. J. Antimicrob. Chemother. 64:69-72.
5. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically - 7th ed. Approved standard M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial disc susceptibility test - 19th ed. Approved standard M2-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing-19th ed. Informational supplement M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA.
8. D'Amato, R. F., C. Thornsberry, C. N. Baker, and L. A. Kirven. 1975. Effect of calcium and magnesium ions on the susceptibility of Pseudomonas species to tetracycline, gentamicin polymyxin B, and carbenicillin. Antimicrob. Agents Chemother. 7:596-600.
9. Fernández-Mazarrasa, C., O. Mazarrasa, J. Calvo, A. del Arco, and L. Martínez-Martínez. 2009. High concentrations of manganese in Mueller-Hinton agar increase MICs of tigecycline determined by Etest. J. Clin. Microbiol. 47:827-829.
10. Kelesidis, T., D. E. Karageorgopoulos, I. Kelesidis, and M. E. Falagas. 2008. Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies. J. Antimicrob. Chemother. 62:895-904.
11. Petersen, P. J., and P. A. Bradford. 2005. Effect of medium age and supplementation with the biocatalytic oxygen-reducing reagent oxyrase on in vitro activities of tigecycline against recent clinical isolates. Antimicrob. Agents Chemother. 49:3910-3918.
12. Pillar, C. M., D. C. Draghi, M. J. Dowzicky, and D. F. Sahm. 2008. In vitro activity of tigecycline against gram-positive and gram-negative pathogens as evaluated by broth microdilution and Etest. J. Clin. Microbiol. 46:2862-2867.
13. Thamlikitkul, V., and S. Tiengrim. 2008. Effect of different Mueller-Hinton agars on tigecycline disc diffusion susceptibility for Acinetobacter spp. J. Antimicrob. Chemother. 62:847-848.
14. Tubau, F., J. Liñares, M. D. Rodríguez, E. Cercenado, M. J. Aldea, F. González-Romo, L. Torroba, P. Berdonces, J. Plazas, L. Aguilar, A. Delgado, and N. García-Escribano on behalf of the study group. 2010. Susceptibility to tigecycline of isolates from samples collected in hospitalized patients with secondary peritonitis undergoing surgery. Diagn. Microbiol. Infect. Dis. 66:308-313.
15. Washington, J. A., II, R. J. Snyder, P. C. Kohner, C. G. Wiltse, D. M. Ilstrup, and J. T. McCall. 1978. Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa. J. Infect. Dis. 137:103-111.